132 related articles for article (PubMed ID: 36146551)
1. An Assessment and Comparison of the Efficacy of Two Licensed Tetravalent Leptospira Vaccines for Dogs Using an Improved Challenge Model.
Klaasen HLBM; Veen MV; Dorrestein-Spierenburg CM; Cao Q
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146551
[TBL] [Abstract][Full Text] [Related]
2. A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs.
Klaasen HL; van der Veen M; Molkenboer MJ; Sutton D
Vet Rec; 2013 Feb; 172(7):181. PubMed ID: 23180149
[TBL] [Abstract][Full Text] [Related]
3. A new tetravalent canine leptospirosis vaccine provides at least 12 months immunity against infection.
Klaasen HL; van der Veen M; Sutton D; Molkenboer MJ
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):26-9. PubMed ID: 24054091
[TBL] [Abstract][Full Text] [Related]
4. Clinical, serological and echocardiographic examination of healthy field dogs before and after vaccination with a commercial tetravalent leptospirosis vaccine.
Spiri AM; Rodriguez-Campos S; Matos JM; Glaus TM; Riond B; Reusch CE; Hofmann-Lehmann R; Willi B
BMC Vet Res; 2017 May; 13(1):138. PubMed ID: 28545521
[TBL] [Abstract][Full Text] [Related]
5. A new multivalent (DHPPi/L4R) canine combination vaccine prevents infection, shedding and clinical signs following experimental challenge with four Leptospira serovars.
Wilson S; Stirling C; Thomas A; King V; Plevová E; Chromá L; Siedek E; Illambas J; Salt J; Sture G
Vaccine; 2013 Jun; 31(31):3131-4. PubMed ID: 23707447
[TBL] [Abstract][Full Text] [Related]
6. A novel octavalent combined Erysipelas, Parvo and Leptospira vaccine provides (cross) protection against infection following challenge of pigs with 9 different
Jacobs A; Harks F; Hoeijmakers M; Segers R
Porcine Health Manag; 2015; 1():16. PubMed ID: 28405422
[TBL] [Abstract][Full Text] [Related]
7. Fifteen-month duration of immunity for the serovar Grippotyphosa fraction of a tetravalent canine leptospirosis vaccine.
Grosenbaugh DA; Pardo MC
Vet Rec; 2018 Jun; 182(23):665. PubMed ID: 29459489
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of changes in the epidemiology of leptospirosis in dogs after introduction of a quadrivalent antileptospiral vaccine in a highly endemic area.
Francey T; Schweighauser A; Reber A; Schuller S
J Vet Intern Med; 2020 Nov; 34(6):2405-2417. PubMed ID: 33103800
[TBL] [Abstract][Full Text] [Related]
9. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine.
Klaasen HL; Molkenboer MJ; Vrijenhoek MP; Kaashoek MJ
Vet Microbiol; 2003 Aug; 95(1-2):121-32. PubMed ID: 12860082
[TBL] [Abstract][Full Text] [Related]
10. A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.
Bouvet J; Lemaitre L; Cariou C; Scotto M; Blain C; Oberli F; Cupillard L; Guigal PM
Vet Immunol Immunopathol; 2020 Jan; 219():109985. PubMed ID: 31759261
[TBL] [Abstract][Full Text] [Related]
11. Duration of immunity of a multivalent (DHPPi/L4R) canine vaccine against four Leptospira serovars.
Wilson S; Stirling C; Thomas A; King V; Plevová E; Chromá L; Siedek E; Illambas J; Salt J; Sture G
Vaccine; 2013 Jun; 31(31):3126-30. PubMed ID: 23707443
[TBL] [Abstract][Full Text] [Related]
12. Prevention of renal carriage of leptospirosis in dogs by vaccination.
Broughton ES; Scarnell J
Vet Rec; 1985 Sep; 117(12):307-11. PubMed ID: 4060538
[TBL] [Abstract][Full Text] [Related]
13. Canine leptospirosis--do we have a problem?
André-Fontaine G
Vet Microbiol; 2006 Oct; 117(1):19-24. PubMed ID: 16684591
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Leptospira serogroups in dogs from Berlin, Germany.
Mayer-Scholl A; Luge E; Draeger A; Nöckler K; Kohn B
Vector Borne Zoonotic Dis; 2013 Mar; 13(3):200-2. PubMed ID: 23428087
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the Leptospira serovars bratislava, grippotyphosa, mozdok and pomona in French dogs.
Renaud C; Andrews S; Djelouadji Z; Lecheval S; Corrao-Revol N; Buff S; Demont P; Kodjo A
Vet J; 2013 Apr; 196(1):126-7. PubMed ID: 23141966
[TBL] [Abstract][Full Text] [Related]
16. Prevention of renal infection and urinary shedding in dogs by a Leptospira vaccination.
Schreiber P; Martin V; Najbar W; Sanquer A; Gueguen S; Lebreux B
Vet Microbiol; 2005 Jun; 108(1-2):113-8. PubMed ID: 15917139
[TBL] [Abstract][Full Text] [Related]
17. MAT cross-reactions or vaccine cross-protection: retrospective study of 863 leptospirosis canine cases.
André-Fontaine G; Triger L
Heliyon; 2018 Nov; 4(11):e00869. PubMed ID: 30426097
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoral immune responsiveness to inactivated Leptospira interrogans in dogs vaccinated with a tetravalent Leptospira vaccine.
Novak A; Hindriks E; Hoek A; Veraart C; Broens EM; Ludwig I; Rutten V; Sloots A; Broere F
Vaccine; 2023 Jan; 41(1):119-129. PubMed ID: 36411135
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a new octavalent combined Erysipelas, Parvo and Leptospira vaccine in gilts against Leptospira interrogans serovar Pomona associated disease and foetal death.
Jacobs AA; Harks F; Hoeijmakers M; Collell M; Segers RP
Vaccine; 2015 Jul; 33(32):3963-9. PubMed ID: 26100922
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis.
André-Fontaine G; Branger C; Gray AW; Klaasen HL
Vet Rec; 2003 Aug; 153(6):165-9. PubMed ID: 12934727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
